BioSpace News Archive

Contrast Vector Imaging Pending FDA Clearance for Premium Aplio i800

Acceleron Pharma Inc. today announced it will host a conference call and live audio webcast on Monday, December 3, 2018 at 9:00 a.m. EST to review the MEDALIST and BELIEVE Phase 3 trial presentations of luspatercept at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition taking place on December 1-4, 2018 in San Diego, California.

27 scientific presentations, including long-term data from CALQUENCE in mantle cell lymphoma and updated early-phase trial results in chronic lymphocytic leukemia

Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) to support the advancement of the Aethlon Hemopurifier® for the treatment of cancer.

- Third Rock Ventures LLC today announced Reid Huber, Ph.D., is joining the firm as a partner.

NetraMark Corp. and Juvenescence Ltd. have partnered to form NetraPharma, a joint venture that is using artificial intelligence technologies to develop therapies that could slow, halt or potentially reverse aging.

MassRoots, Inc. announced today that MassRoots will be presenting at the 11th Annual LD Micro Main Event which will be held on December 4-6, 2018 at the Luxe Sunset Blvd Hotel in Los Angeles.

Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.

Daiichi Sankyo Company, Limited announced today that it has entered into an agreement with Roche to collaborate on the development of a new HER2 low companion diagnostic test.